Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADC Agree

Not Yet Opened 02-10 16:00:00 EST

76.51

+1.21

+1.61%

盘后76.51

+0.000.00%

18:46 EST

High76.71	Low75.47	Vol1.30M
Open75.49	D1 Closing75.30	Amplitude1.65%
Mkt Cap8.79B	Tradable Cap8.29B	Total Shares114.93M
T/O99.07M	T/O Rate1.20%	Tradable Shares108.37M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"Agree","latestPrice":76.51,"timestamp":1770757200000,"preClose":75.3,"halted":0,"volume":1297336,"hourTrading":{"tag":"盘后","latestPrice":76.51,"preClose":76.51,"latestTime":"18:46 EST","volume":17616,"amount":1347843.4936,"timestamp":1770767174118,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.016069057104913784,"floatShares":108366822,"shares":114934390,"eps":1.712089,"marketStatus":"Not Yet Opened","change":1.21,"latestTime":"02-10 16:00:00 EST","open":75.49,"high":76.705,"low":75.465,"amount":99065705.64232,"amplitude":0.016467,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.712089,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770800400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":75.3,"dividendRate":0.039916,"preHourTrading":{"tag":"盘前","latestPrice":75.65,"preClose":75.3,"latestTime":"09:20 EST","volume":125,"amount":9453.351250000002,"timestamp":1770733242729,"change":0.35,"changeRate":0.004648,"amplitude":0.022311},"postHourTrading":{"tag":"盘后","latestPrice":76.51,"preClose":76.51,"latestTime":"18:46 EST","volume":17616,"amount":1347843.4936,"timestamp":1770767174118,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.026546,"impliedVol":0.2218,"impliedVolPercentile":0.502},"requestUrl":"/m/hq/s/ADC","defaultTab":"news","newsList":[{"id":"2610867666","title":"Agree Realty Q4 FFO $1.11 Beats $1.10 Estimate, Sales $190.489M Beat $185.501M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2610867666","media":"Benzinga","labels":["dataReport","express"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2610867666?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:05","pubTimestamp":1770757557,"startTime":"0","endTime":"0","summary":"Agree Realty (NYSE:ADC) reported quarterly earnings of $1.11 per share which beat the analyst consensus estimate of $1.10 by 1.28 percent. This is a 6.73 percent increase over earnings of $1.04 per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50526140/agree-realty-q4-ffo-1-11-beats-1-10-estimate-sales-190-489m-beat-185-501m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Agree Realty Q4 FFO $1.11 Beats $1.10 Estimate, Sales $190.489M Beat $185.501M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC"],"gpt_icon":0},{"id":"2610567221","title":"Sutro Biopharma Highlights ADC Platform in New Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2610567221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610567221?lang=en_us&edition=fundamental","pubTime":"2026-02-11 06:50","pubTimestamp":1770763800,"startTime":"0","endTime":"0","summary":"Sutro Biopharma ( ($STRO) ) has provided an update. On February 9, 2026, Sutro Biopharma entered an underwriting agreement with Leerink Partners an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sutro-biopharma-highlights-adc-platform-in-new-presentation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sutro-biopharma-highlights-adc-platform-in-new-presentation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2610679250","title":"GUIDANCE: (ADC) Agree Realty Expects Full Year 2026 AFFO Range $4.54 - $4.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2610679250","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610679250?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:24","pubTimestamp":1770758693,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ADC) Agree Realty Expects Full Year 2026 AFFO Range $4.54 - $4.58","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4231","BK4080","ADC.AU","ADC","BK7095"],"gpt_icon":0},{"id":"2610679842","title":"Agree Realty Q4 net income per share rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2610679842","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610679842?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:17","pubTimestamp":1770758231,"startTime":"0","endTime":"0","summary":"Agree Realty Q4 net income per share risesOverviewReal estate investment trust's Q4 net income per share rose 13.5% yr/yrCore FFO per share for Q4 increased 7.3% yr/yrCompany provided 2026 AFFO per sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nL1N3Z61A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2610467965","title":"Agree Realty reports Q4 AFFO $1.11, consensus $1.10","url":"https://stock-news.laohu8.com/highlight/detail?id=2610467965","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610467965?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:12","pubTimestamp":1770757922,"startTime":"0","endTime":"0","summary":"“We are pleased with our performance during 2025, investing approximately $1.55 billion to further strengthen our best-in-class retail portfolio,” ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agree-realty-reports-q4-affo-1-11-consensus-1-10-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agree-realty-reports-q4-affo-1-11-consensus-1-10-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","BK4080","ADC"],"gpt_icon":0},{"id":"2610867993","title":"Agree Realty sees FY26 AFFO $4.54-$4.58, consensus $4.53","url":"https://stock-news.laohu8.com/highlight/detail?id=2610867993","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610867993?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:11","pubTimestamp":1770757892,"startTime":"0","endTime":"0","summary":"16:08 EST Agree Realty (ADC) sees FY26 AFFO $4.54-$4.58, consensus $4.53 Published first on TheFly – the ultimate source for real-time, market-movi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agree-realty-sees-fy26-affo-4-54-4-58-consensus-4-53-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agree-realty-sees-fy26-affo-4-54-4-58-consensus-4-53-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2610769146","title":"ADC Q4 net income attributable to common stockholders at USD 54.18 million, up 25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610769146","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610769146?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:08","pubTimestamp":1770757689,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agree Realty Corporation published the original content used to generate this news brief via Business Wire  on February 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL6TjzwG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2610610676","title":"BRIEF-Agree Realty Q4 Core FFO Per Share USD 1.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2610610676","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610610676?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:05","pubTimestamp":1770757546,"startTime":"0","endTime":"0","summary":"BRIEF-Agree Realty Q4 Core FFO Per Share USD 1.1\n\n\nFeb 10 (Reuters) - Agree Realty Q4 net income USD 56.209 million.\n\nQ4 EPS USD 0.47\nQ4 core FFO USD 126.8 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nPLX16E31F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2610796186","title":"Agree Realty Outlook FY Adjusted Ffo per Share USD 4.54-4.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2610796186","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610796186?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:05","pubTimestamp":1770757502,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nPLX16E31F:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2610690679","title":"Agree Realty: on Track to Achieve 2026 Affo per Share Guidance of $4.54 to $4.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2610690679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610690679?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:05","pubTimestamp":1770757502,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nPLX16E31F:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","BK4231","ADC"],"gpt_icon":0},{"id":"2610320676","title":"Agree Realty Q4 Core Ffo USD 126.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610320676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610320676?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:05","pubTimestamp":1770757502,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nPLX16E31F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","ADC","BK4231"],"gpt_icon":0},{"id":"2610267566","title":"U.S. Earnings Preview: After Market Close Feb. 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2610267566","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610267566?lang=en_us&edition=fundamental","pubTime":"2026-02-11 04:31","pubTimestamp":1770755460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results after the market closes.Gilead Sciences Inc.'s fourth-quarter EPS is forecast at $1.58, compared with $1.42 in the prior-year period. Adjusted EPS is forecast at $1.81.Welltower Inc.'s fourth-quarter EPS is forecast at 58 cents, compared with 19 cents in the prior-year period.Robinhood Markets Inc.'s fourth-quarter EPS is forecast at 63 cents.Cloudflare Inc.'s fourth-quarter EPS is forecast at a loss of 3 cents, compared with a loss of 4 cents in the prior-year period. Adjusted EPS is forecast at 27 cents.American International Group Inc.'s fourth-quarter EPS is forecast at $1.84, compared with $1.43 in the prior-year period. Adjusted EPS is forecast at $1.90.Omnicom Group Inc.'s fourth-quarter EPS is forecast at $2.55, compared with $2.26 in the prior-year period. Adjusted EPS is forecast at $2.70.Assur","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","BK4547","EW","HOOD","BK4139","LU1861559042.SGD","LU2324357040.USD","BK4560","LU0130517989.USD","HOOG","GILD","IE00B19Z3581.USD","LU2286300806.USD","WELL","SG9999015986.USD","LU2065171402.SGD","IE00B3T34201.USD","Z","LU2065169927.USD","BK4568","AIZ","LU0345774391.USD","LU1430594728.SGD","BK4127","LU0648000940.SGD","LU1201861165.SGD","LU1066051498.USD","HOOW","IE00BZ1G4Q59.USD","IE00BN0W2T93.GBP","LU2087621335.USD","LU1571399168.USD","LU0980610538.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","BK4554","LU0234570918.USD","LU0130102774.USD","BK4082","LU0477156797.USD","BK4117","ADC","LU1066053197.SGD","NET","IE00BYQQ9H92.USD","BK4532","HOOI","BK4548","BK4567","LU0289739699.SGD","LU1668664300.SGD","IE00BFXG1179.USD","BK4203","LU1674673691.USD","HODU","EXEL","SG9999001176.USD","LU2065171311.SGD","HOOZ","LU0072461881.USD","BK4585","BK4116","LU0130518102.USD","AIG","ROBN","IE00BN0W2V16.EUR","BK4607","IE00B7SZLL34.SGD","LU1839511570.USD","LU2089984988.USD","LU0345774631.USD","LU0109394709.USD","LU0106831901.USD","LU0114720955.EUR","BK4578","IE00BKVL7J92.USD","LU0130103400.USD","AEIS","LU0882574055.USD","BK4588","IE00BN0W2W23.USD","LU1674673428.USD","OMC","LU2065170008.USD","LSCC","LU0823416689.USD","LU0320765992.SGD","SGXZ57979304.SGD","SG9999001176.SGD","LU0889565916.HKD","BK4225","BK4107","HOOY","LU1778281490.HKD","BK4566","PEGA","LU0477156953.USD","SG9999015952.SGD","LU1861558580.USD","LU0058720904.USD","F","LU0648001328.SGD","HOOX","HOYY","LU1201861249.SGD","IE00BSNM7G36.USD","BK4613","LU0162691827.USD","BK4539","IE00BFXG0V08.USD","LU1585245621.USD","SG9999015978.USD","BK4504","BK4550","SG9999013999.USD","BK4583","SG9999015945.SGD"],"gpt_icon":0},{"id":"2610623727","title":"Defence Therapeutics Refines Accum ADC Strategy With New Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2610623727","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610623727?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:38","pubTimestamp":1770730720,"startTime":"0","endTime":"0","summary":"Defence Therapeutics ( ($TSE:DTC) ) has shared an announcement. Defence Therapeutics has convened a multidisciplinary Scientific Advisory Board to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-refines-accum-adc-strategy-with-new-scientific-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-refines-accum-adc-strategy-with-new-scientific-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","BK4231","LENZ","BK4080","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2610862533","title":"Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610862533","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610862533?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:30","pubTimestamp":1770730200,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif., Feb.  10, 2026  (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing ta","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/10/3235322/0/en/Day-One-To-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-Tuesday-February-24-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4231","ADC"],"gpt_icon":0},{"id":"2610642658","title":"Press Release: Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2610642658","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610642658?lang=en_us&edition=fundamental","pubTime":"2026-02-10 20:00","pubTimestamp":1770724800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Feb. 10, 2026  -- Sutro Biopharma, Inc.  , a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates , today announced the pricing of an underwritten offering of 7,868,383 shares of its common stock at a price of $13.98 per share. The gross proceeds from this offering are expected to be approximately $110.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Sutro. All of the shares of common stock are being offered by Sutro. The offering is expected to close on or about February 11, 2026, subject to the satisfaction of customary closing conditions.This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Sutro, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the se","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","ADC","STRO","BK4139","USA","BK4231"],"gpt_icon":0},{"id":"1198450488","title":"Southwest Securities: Broad Market Potential for Driver Gene-Negative NSCLC, with Dual/Multi-Specific Antibodies and IO+ADC Therapies Advancing Together","url":"https://stock-news.laohu8.com/highlight/detail?id=1198450488","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198450488?lang=en_us&edition=fundamental","pubTime":"2026-02-10 15:00","pubTimestamp":1770706848,"startTime":"0","endTime":"0","summary":"Southwest Securities has released a research report indicating that the current first-line treatment for advanced driver gene-negative non-small cell lung cancer (NSCLC) primarily relies on PD-(L)1...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","600369","BK4080","BK0183","BK0012","BK0276","BK0028","BK0188","BK4231"],"gpt_icon":0},{"id":"2610698674","title":"Why Doctors Can't Agree on How to Diagnose Alzheimer's -- Your Health -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2610698674","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610698674?lang=en_us&edition=fundamental","pubTime":"2026-02-10 09:00","pubTimestamp":1770685200,"startTime":"0","endTime":"0","summary":"Imagine you're in your late 60s and are diagnosed with Alzheimer's disease.You start planning the rest of your life: telling your spouse you may eventually become incapacitated; looking into long-term memory care; checking off as many bucket list items as you can.Six months later, another neurologist finds the opposite: You don't have Alzheimer's and aren't at risk of developing it.He was then started on monoclonal antibodies despite the fact that he didn't need them. A subsequent spinal tap showed no amyloid or tau. The patient didn't have Alzheimer's disease and isn't expected to develop it given his late-60s age and the fact that it takes years for amyloid plaques to build up, she says.\"Many people who are worried about prevention will go for testing,\" she says. \"A lot of us have memory issues. We are all multitasking. So symptoms are difficult to define and difficult to self access.\". Amyloid alone shouldn't define Alzheimer's disease, she says. Roughly 25% to 45% of seniors with n","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"1126570572","title":"Chinese Pharmaceutical Firm Completes Patient Enrollment for Phase III Trial of HER2-Targeting Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1126570572","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126570572?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:24","pubTimestamp":1770675864,"startTime":"0","endTime":"0","summary":"SINO BIOPHARM (01177) announced that the Group's self-developed Class 1 innovative drug, TQB2102, a HER2-targeting bispecific antibody-drug conjugate, has completed patient enrollment for a Phase III...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK4134","IE00BZ08YR35.GBP","BK1191","01177","BK1521","III","BK4231","IE00BZ08YS42.EUR","ADC","IE00BZ08YT58.USD","HK0000165453.HKD","BK1589","BK4080"],"gpt_icon":0},{"id":"2610577476","title":"A Look At Agree Realty (ADC) Valuation After The Latest Monthly Dividend Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2610577476","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610577476?lang=en_us&edition=fundamental","pubTime":"2026-02-09 23:20","pubTimestamp":1770650415,"startTime":"0","endTime":"0","summary":"Agree Realty (ADC) just announced a higher monthly cash dividend of $0.262 per common share, representing a 3.6% annualized increase and highlighting its focus on income for shareholders.\nSee our latest analysis for Agree Realty.\nThe dividend increase comes as Agree Realty’s share price sits at $74.74, with a 7-day share price return of 5.21% and a 30-day share price return of 6.00%. The 1-year total shareholder return of 7.06% and 5-year total shareholder return of 42.05% suggest momentum...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/a-look-at-agree-realty-adc-valuation-after-the-latest-monthl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/a-look-at-agree-realty-adc-valuation-after-the-latest-monthl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7095","ADC.AU","ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2610316506","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2610316506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610316506?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:00","pubTimestamp":1770634800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKR","CCSI","ANGI","DD","CLF","AVXL","MNTN","RACE","AIG","ADC","AZN","BDX","BCS","CAN","DDOG","ACGL","ACRE","AMKR","AMX","AXTA","DGX","DUK","ACM","DIOD","DEI","CINF","BL","AIZ","CRBG","ARI","EXEL","EPC","AEIS","AIOT","KO","AMTM","BLKB","BRX","BP","CMCO","APO","EW","ENTG","DT","F","ALAB","ECL","CURB","ENTA","ARMK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agreerealty.com","stockEarnings":[{"period":"1week","weight":0.0597},{"period":"1month","weight":0.0851},{"period":"3month","weight":0.0432},{"period":"6month","weight":0.0603},{"period":"1year","weight":0.0508},{"period":"ytd","weight":0.0622}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agree Realty Corporation (the Company), a Maryland corporation, is a fully integrated real estate investment trust (REIT) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (GLA) of approximately 44.9 million square feet.","yearOnYearQuotes":[{"month":1,"riseRate":0.59375,"avgChangeRate":-0.003579},{"month":2,"riseRate":0.46875,"avgChangeRate":0.000469},{"month":3,"riseRate":0.580645,"avgChangeRate":0.015289},{"month":4,"riseRate":0.580645,"avgChangeRate":0.002795},{"month":5,"riseRate":0.5,"avgChangeRate":0.015633},{"month":6,"riseRate":0.65625,"avgChangeRate":0.010123},{"month":7,"riseRate":0.65625,"avgChangeRate":0.022845},{"month":8,"riseRate":0.46875,"avgChangeRate":0.002201},{"month":9,"riseRate":0.46875,"avgChangeRate":-0.006321},{"month":10,"riseRate":0.5625,"avgChangeRate":-0.000339},{"month":11,"riseRate":0.65625,"avgChangeRate":0.003584},{"month":12,"riseRate":0.46875,"avgChangeRate":0.00994}],"exchange":"NYSE","name":"Agree","nameEN":"Agree"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agree,ADC,Agree股票,Agree股票老虎,Agree股票老虎国际,Agree行情,Agree股票行情,Agree股价,Agree股市,Agree股票价格,Agree股票交易,Agree股票购买,Agree股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}